US 12161618
Methods of identifying and treating patients with HIF-2 inhibitor resistance
granted A61KA61K31/275A61K31/277
Quick answer
US patent 12161618 (Methods of identifying and treating patients with HIF-2 inhibitor resistance) held by The Board of Regents of the University of Texas System expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/275, A61K31/277, A61K45/06